CAL
MBII

Capital Analysts LLC’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Capital Analysts LLC’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-957
Closed -$1K – 1048
2021
Q3 		$1K Buy
+957
New +$1.15K ﹤0.01% 978

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Analysts LLC's MBII Position: Q4 2021 in Review

Capital Analysts LLC sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2021, closing a stake of 957 shares — an estimated $1K sold.

Capital Analysts LLC first reported a position in MBII in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 74 funds tracked by Wall St. Rank hold MBII as of Q4 2021.

  • Capital Analysts LLC reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2021 after selling out during the quarter.
  • Capital Analysts LLC sold 957 Marrone Bio Innovations, Inc. shares in Q4 2021, an estimated $1K.
  • Capital Analysts LLC first reported a position in Marrone Bio Innovations, Inc. in Q3 2021 and held it in 1 quarter.
  • Capital Analysts LLC's Marrone Bio Innovations, Inc. position peaked at $1K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2021.

Based on Capital Analysts LLC's 13F filing for Q4 2021, filed 10 Feb 2022.